Nature Communications,
Год журнала:
2022,
Номер
13(1)
Опубликована: Янв. 10, 2022
Abstract
Glioblastoma
is
an
aggressive
form
of
brain
cancer
with
well-established
patterns
intra-tumoral
heterogeneity
implicated
in
treatment
resistance
and
progression.
While
regional
single
cell
transcriptomic
variations
glioblastoma
have
been
recently
resolved,
downstream
phenotype-level
proteomic
programs
yet
to
be
assigned
across
glioblastoma’s
hallmark
histomorphologic
niches.
Here,
we
leverage
mass
spectrometry
spatially
align
abundance
levels
4,794
proteins
distinct
histologic
20
patients
propose
diverse
molecular
operational
within
these
tumor
compartments.
Using
machine
learning,
overlay
concordant
transcriptional
information,
define
two
proteogenomic
programs,
MYC-
KRAS-axis
hereon,
that
cooperate
hypoxia
produce
a
tri-dimensional
model
heterogeneity.
Moreover,
highlight
differential
drug
sensitivities
relative
chemoresistance
lines
enhanced
KRAS
programs.
Importantly,
pharmacological
differences
are
less
pronounced
subgroups
suggesting
this
may
provide
insights
for
targeting
overcoming
therapy
resistance.
Abstract
Heatmap
is
a
widely
used
statistical
visualization
method
on
matrix‐like
data
to
reveal
similar
patterns
shared
by
subsets
of
rows
and
columns.
In
the
R
programming
language,
there
are
many
packages
that
make
heatmaps.
Among
them,
ComplexHeatmap
package
provides
richest
toolset
for
constructing
highly
customizable
can
easily
establish
connections
between
multisource
information
automatically
concatenating
adjusting
list
heatmaps
as
well
complex
annotations,
which
makes
it
applied
in
analysis
fields,
especially
bioinformatics,
find
hidden
structures
data.
this
article,
we
give
comprehensive
introduction
current
state
,
including
its
modular
design,
rich
functionalities,
broad
applications.
Signal Transduction and Targeted Therapy,
Год журнала:
2023,
Номер
8(1)
Опубликована: Март 20, 2023
Metabolic
abnormalities
lead
to
the
dysfunction
of
metabolic
pathways
and
metabolite
accumulation
or
deficiency
which
is
well-recognized
hallmarks
diseases.
Metabolite
signatures
that
have
close
proximity
subject's
phenotypic
informative
dimension,
are
useful
for
predicting
diagnosis
prognosis
diseases
as
well
monitoring
treatments.
The
lack
early
biomarkers
could
poor
serious
outcomes.
Therefore,
noninvasive
methods
with
high
specificity
selectivity
desperately
needed.
Small
molecule
metabolites-based
metabolomics
has
become
a
specialized
tool
biomarker
pathway
analysis,
revealing
possible
mechanisms
human
various
deciphering
therapeutic
potentials.
It
help
identify
functional
related
variation
delineate
biochemical
changes
indicators
pathological
damage
prior
disease
development.
Recently,
scientists
established
large
number
profiles
reveal
underlying
networks
target
exploration
in
biomedicine.
This
review
summarized
analysis
on
potential
value
small-molecule
candidate
metabolites
clinical
events,
may
better
diagnosis,
prognosis,
drug
screening
treatment.
We
also
discuss
challenges
need
be
addressed
fuel
next
wave
breakthroughs.
Cell,
Год журнала:
2021,
Номер
184(19), С. 5031 - 5052.e26
Опубликована: Сен. 1, 2021
Pancreatic
ductal
adenocarcinoma
(PDAC)
is
a
highly
aggressive
cancer
with
poor
patient
survival.
Toward
understanding
the
underlying
molecular
alterations
that
drive
PDAC
oncogenesis,
we
conducted
comprehensive
proteogenomic
analysis
of
140
pancreatic
cancers,
67
normal
adjacent
tissues,
and
9
tissues.
Proteomic,
phosphoproteomic,
glycoproteomic
analyses
were
used
to
characterize
proteins
their
modifications.
In
addition,
whole-genome
sequencing,
whole-exome
methylation,
RNA
sequencing
(RNA-seq),
microRNA
(miRNA-seq)
performed
on
same
tissues
facilitate
an
integrated
determine
impact
genomic
protein
expression,
signaling
pathways,
post-translational
To
ensure
robust
downstream
analyses,
tumor
neoplastic
cellularity
was
assessed
via
multiple
orthogonal
strategies
using
features
verified
pathological
estimation
based
histological
review.
This
characterization
will
serve
as
valuable
resource
for
community,
paving
way
early
detection
identification
novel
therapeutic
targets.
Cell,
Год журнала:
2021,
Номер
184(16), С. 4348 - 4371.e40
Опубликована: Авг. 1, 2021
Lung
squamous
cell
carcinoma
(LSCC)
remains
a
leading
cause
of
cancer
death
with
few
therapeutic
options.
We
characterized
the
proteogenomic
landscape
LSCC,
providing
deeper
exposition
LSCC
biology
potential
implications.
identify
NSD3
as
an
alternative
driver
in
FGFR1-amplified
tumors
and
low-p63
overexpressing
target
survivin.
SOX2
is
considered
undruggable,
but
our
analyses
provide
rationale
for
exploring
chromatin
modifiers
such
LSD1
EZH2
to
SOX2-overexpressing
tumors.
Our
data
support
complex
regulation
metabolic
pathways
by
crosstalk
between
post-translational
modifications
including
ubiquitylation.
Numerous
immune-related
observations
suggest
directions
further
investigation.
Proteogenomic
dissection
CDKN2A
mutations
argue
more
nuanced
assessment
RB1
protein
expression
phosphorylation
before
declaring
CDK4/6
inhibition
unsuccessful.
Finally,
triangulation
LUAD,
HNSCC
identified
both
unique
common
vulnerabilities.
These
proteogenomics
resources
may
guide
research
into
treatment
LSCC.
Cell,
Год журнала:
2020,
Номер
183(7), С. 1962 - 1985.e31
Опубликована: Ноя. 25, 2020
We
report
a
comprehensive
proteogenomics
analysis,
including
whole-genome
sequencing,
RNA
and
proteomics
phosphoproteomics
profiling,
of
218
tumors
across
7
histological
types
childhood
brain
cancer:
low-grade
glioma
(n
=
93),
ependymoma
(32),
high-grade
(25),
medulloblastoma
(22),
ganglioglioma
(18),
craniopharyngioma
(16),
atypical
teratoid
rhabdoid
tumor
(12).
Proteomics
data
identify
common
biological
themes
that
span
boundaries,
suggesting
treatments
used
for
one
type
may
be
applied
effectively
to
other
sharing
similar
features.
Immune
landscape
characterization
reveals
diverse
microenvironments
within
diagnoses.
further
reveal
functional
effects
somatic
mutations
copy
number
variations
(CNVs)
not
evident
in
transcriptomics
data.
Kinase-substrate
association
co-expression
network
analysis
important
mechanisms
tumorigenesis.
This
is
the
first
large-scale
traditional
boundaries
uncover
foundational
pediatric
biology
inform
rational
treatment
selection.
iScience,
Год журнала:
2022,
Номер
25(2), С. 103798 - 103798
Опубликована: Янв. 22, 2022
Multi-omics
data
analysis
is
an
important
aspect
of
cancer
molecular
biology
studies
and
has
led
to
ground-breaking
discoveries.
Many
efforts
have
been
made
develop
machine
learning
methods
that
automatically
integrate
omics
data.
Here,
we
review
tools
categorized
as
either
general-purpose
or
task-specific,
covering
both
supervised
unsupervised
for
integrative
multi-omics
We
benchmark
the
performance
five
approaches
using
from
Cancer
Cell
Line
Encyclopedia,
reporting
accuracy
on
type
classification
mean
absolute
error
drug
response
prediction,
evaluating
runtime
efficiency.
This
provides
recommendations
researchers
regarding
suitable
method
selection
their
specific
applications.
It
should
also
promote
development
novel
methodologies
integration,
which
will
be
essential
discovery,
clinical
trial
design,
personalized
treatments.
Nature Communications,
Год журнала:
2022,
Номер
13(1)
Опубликована: Май 13, 2022
Abstract
Mass-spectrometry-based
proteomic
data
on
human
tumors—combined
with
corresponding
multi-omics
data—present
opportunities
for
systematic
and
pan-cancer
proteogenomic
analyses.
Here,
we
assemble
a
compendium
dataset
of
proteomics
2002
primary
tumors
from
14
cancer
types
17
studies.
Protein
expression
genes
broadly
correlates
mRNA
levels
or
copy
number
alterations
(CNAs)
across
tumors,
but
notable
exceptions.
Based
unsupervised
clustering,
separate
into
11
distinct
proteome-based
subtypes
spanning
multiple
tissue-based
types.
Two
are
enriched
brain
one
subtype
associating
MYC,
Wnt,
Hippo
pathways
high
CNA
burden,
another
metabolic
low
burden.
Somatic
alteration
in
pathway
associates
higher
activity
as
inferred
by
proteome
transcriptome
data.
A
substantial
fraction
cancers
shows
MYC
without
gain
mutations
noncanonical
roles
MYC.
Our
proteogenomics
survey
reveals
the
interplay
between
genome
tumor
lineages.
Cancer Cell,
Год журнала:
2023,
Номер
41(4), С. 678 - 692.e7
Опубликована: Март 9, 2023
A
better
understanding
of
transcriptional
evolution
IDH-wild-type
glioblastoma
may
be
crucial
for
treatment
optimization.
Here,
we
perform
RNA
sequencing
(RNA-seq)
(n
=
322
test,
n
245
validation)
on
paired
primary-recurrent
resections
patients
treated
with
the
current
standard
care.
Transcriptional
subtypes
form
an
interconnected
continuum
in
a
two-dimensional
space.
Recurrent
tumors
show
preferential
mesenchymal
progression.
Over
time,
hallmark
genes
are
not
significantly
altered.
Instead,
tumor
purity
decreases
over
time
and
is
accompanied
by
co-increases
neuron
oligodendrocyte
marker
and,
independently,
tumor-associated
macrophages.
decrease
observed
endothelial
genes.
These
composition
changes
confirmed
single-cell
RNA-seq
immunohistochemistry.
An
extracellular
matrix-associated
gene
set
increases
at
recurrence
bulk,
RNA,
immunohistochemistry
indicate
it
expressed
mainly
pericytes.
This
signature
associated
worse
survival
recurrence.
Our
data
demonstrate
that
glioblastomas
evolve
microenvironment
(re-)organization
rather
than
molecular
cells.